Connect Biopharma Holdings (CNTB) has released an update.
Connect Biopharma Holdings Limited has announced the transition of two key figures, Dr. Zheng Wei and Dr. Wubin Pan, to non-executive roles within the company. Dr. Zheng Wei will serve as Senior Advisor and Dr. Wubin Pan as General Manager of Greater China Operations, each with a respective base salary and continued benefits until the end of 2024 or until their employment termination. These changes are now part of the company’s official filings with the Securities and Exchange Commission.
For further insights into CNTB stock, check out TipRanks’ Stock Analysis page.
